Kamil Kuś

922 total citations
31 papers, 690 citations indexed

About

Kamil Kuś is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Kamil Kuś has authored 31 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Physiology and 6 papers in Biochemistry. Recurrent topics in Kamil Kuś's work include Nitric Oxide and Endothelin Effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Kamil Kuś is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Kamil Kuś collaborates with scholars based in Poland, United States and Germany. Kamil Kuś's co-authors include Stefan Chłopicki, Maria Walczak, Agnieszka Kij, Agnieszka Zakrzewska, Marta Stojak, Thomas Münzel, Johanna Helmstädter, Sanela Kalinovic, Matthias Oelze and Sebastian Steven and has published in prestigious journals such as International Journal of Molecular Sciences, Arteriosclerosis Thrombosis and Vascular Biology and Frontiers in Immunology.

In The Last Decade

Kamil Kuś

28 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamil Kuś Poland 14 258 176 113 97 81 31 690
Davoud Sanajou Iran 16 242 0.9× 167 0.9× 62 0.5× 92 0.9× 48 0.6× 26 740
Srinivasan Vedantham India 13 293 1.1× 93 0.5× 109 1.0× 104 1.1× 39 0.5× 29 769
Szilvia Török Hungary 17 330 1.3× 111 0.6× 125 1.1× 90 0.9× 109 1.3× 43 917
Melek Öztürk Türkiye 16 218 0.8× 125 0.7× 97 0.9× 45 0.5× 44 0.5× 49 816
Caterina Constantinou Greece 16 287 1.1× 170 1.0× 139 1.2× 72 0.7× 36 0.4× 32 636
Sarah Will United States 15 239 0.9× 200 1.1× 163 1.4× 70 0.7× 44 0.5× 28 626
Alina Hanf Germany 6 185 0.7× 203 1.2× 114 1.0× 145 1.5× 49 0.6× 6 555
Xuemei Wang China 18 237 0.9× 82 0.5× 95 0.8× 65 0.7× 50 0.6× 37 731
Jun Song China 14 406 1.6× 277 1.6× 142 1.3× 57 0.6× 38 0.5× 31 832

Countries citing papers authored by Kamil Kuś

Since Specialization
Citations

This map shows the geographic impact of Kamil Kuś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamil Kuś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamil Kuś more than expected).

Fields of papers citing papers by Kamil Kuś

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamil Kuś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamil Kuś. The network helps show where Kamil Kuś may publish in the future.

Co-authorship network of co-authors of Kamil Kuś

This figure shows the co-authorship network connecting the top 25 collaborators of Kamil Kuś. A scholar is included among the top collaborators of Kamil Kuś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamil Kuś. Kamil Kuś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Brzózka, Krzysztof, et al.. (2024). Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction. Drug Metabolism and Pharmacokinetics. 57. 101023–101023.
3.
Kieronska‐Rudek, Anna, Agnieszka Kij, Anna Bar, et al.. (2024). Phylloquinone improves endothelial function, inhibits cellular senescence, and vascular inflammation. GeroScience. 46(5). 4909–4935. 5 indexed citations
4.
Totoń‐Żurańska, Justyna, Grzegorz Kwiatkowski, Agnieszka Jasztal, et al.. (2023). Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tgαq*44 mice. GeroScience. 45(3). 1619–1648. 7 indexed citations
5.
Walczak, Maria, Joanna Suraj, Kamil Kuś, Agnieszka Kij, & Grażyna Groszek. (2021). A preliminary metabolites identification of a novel compound with β-adrenolytic activity. Pharmacological Reports. 73(5). 1373–1389. 1 indexed citations
6.
Kaczara, Patrycja, Barbara Sitek, Kamil Przyborowski, et al.. (2020). Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD + and ATP Depletion. Arteriosclerosis Thrombosis and Vascular Biology. 40(10). 2376–2390. 29 indexed citations
7.
Kamiński, Krzysztof, Szczepan Mogilski, Michał Abram, et al.. (2020). KA‐104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models. Epilepsia. 61(10). 2119–2128. 11 indexed citations
8.
Steven, Sebastian, Katie Frenis, Sanela Kalinovic, et al.. (2020). Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension. Redox Biology. 34. 101515–101515. 37 indexed citations
10.
Szczęsny-Małysiak, Ewa, Jakub Dybaś, Katarzyna Bułat, et al.. (2020). Irreversible alterations in the hemoglobin structure affect oxygen binding in human packed red blood cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(11). 118803–118803. 24 indexed citations
11.
Bar, Anna, Kamil Kuś, Bartosz Proniewski, et al.. (2019). Vitamin K2-MK-7 improves nitric oxide-dependent endothelial function in ApoE/LDLR−/− mice. Vascular Pharmacology. 122-123. 106581–106581. 26 indexed citations
12.
Sternak, Magdalena, Anna Bar, Mateusz Adamski, et al.. (2018). The Deletion of Endothelial Sodium Channel α (αENaC) Impairs Endothelium-Dependent Vasodilation and Endothelial Barrier Integrity in Endotoxemia in Vivo. Frontiers in Pharmacology. 9. 178–178. 33 indexed citations
13.
Kuś, Kamil, Agnieszka Kij, Agnieszka Zakrzewska, et al.. (2018). Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics. Breast Cancer Research. 20(1). 148–148. 46 indexed citations
15.
Kaczara, Patrycja, Bartosz Proniewski, Christopher Lovejoy, et al.. (2018). CORM‐401 induces calcium signalling, NO increase and activation of pentose phosphate pathway in endothelial cells. FEBS Journal. 285(7). 1346–1358. 25 indexed citations
16.
Kuś, Kamil, Edyta Kuś, Agnieszka Zakrzewska, et al.. (2017). Differential effects of liver steatosis on pharmacokinetic profile of two closely related hepatoselective NO-donors; V-PYRRO/NO and V-PROLI/NO. Pharmacological Reports. 69(3). 560–565. 3 indexed citations
17.
Kuś, Kamil, Agnieszka Zakrzewska, Małgorzata Szafarz, et al.. (2015). Validation of LC/MS/MS method for assessment of the in vitro activity of the selected rat cytochrome P450 isoenzymes - application to early drug metabolism screening. Jagiellonian University Repository (Jagiellonian University). 1 indexed citations
18.
Kuś, Kamil, Maria Walczak, Edyta Maślak, et al.. (2015). Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics. Drug Metabolism and Disposition. 43(7). 1028–1036. 16 indexed citations
19.
Maślak, Edyta, Piotr Zabielski, Kamila Kochan, et al.. (2014). The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. Biochemical Pharmacology. 93(3). 389–400. 34 indexed citations
20.
Kuś, Kamil, et al.. (2013). Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.. PubMed. 70(4). 631–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026